Parametric Portfolio Associates’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $3.35M | Buy |
201,038
+21,372
| +12% | +$356K | ﹤0.01% | 2116 |
|
|
2021
Q4 | $3.43M | Sell |
179,666
-351,115
| -66% | -$6.7M | ﹤0.01% | 2109 |
|
|
2021
Q3 | $13.1M | Buy |
530,781
+263,782
| +99% | +$6.5M | 0.01% | 1184 |
|
|
2021
Q2 | $6.95M | Buy |
266,999
+77,965
| +41% | +$2.03M | ﹤0.01% | 1632 |
|
|
2021
Q1 | $5.99M | Buy |
189,034
+62,618
| +50% | +$1.98M | ﹤0.01% | 2040 |
|
|
2020
Q4 | $5.87M | Buy |
126,416
+15,451
| +14% | +$717K | ﹤0.01% | 1966 |
|
|
2020
Q3 | $3.65M | Sell |
110,965
-38,051
| -26% | -$1.25M | ﹤0.01% | 2110 |
|
|
2020
Q2 | $4.09M | Buy |
149,016
+37,013
| +33% | +$1.02M | ﹤0.01% | 2016 |
|
|
2020
Q1 | $3.35M | Buy |
112,003
+24,586
| +28% | +$736K | ﹤0.01% | 2030 |
|
|
2019
Q4 | $2.42M | Buy |
87,417
+860
| +1% | +$23.8K | ﹤0.01% | 2571 |
|
|
2019
Q3 | $1.58M | Buy |
86,557
+239
| +0.3% | +$4.35K | ﹤0.01% | 2790 |
|
|
2019
Q2 | $2.12M | Buy |
86,318
+64,405
| +294% | +$1.58M | ﹤0.01% | 2635 |
|
|
2019
Q1 | $208K | Sell |
21,913
-478
| -2% | -$4.54K | ﹤0.01% | 3709 |
|
|
2018
Q4 | $198K | Buy |
22,391
+4,054
| +22% | +$35.8K | ﹤0.01% | 3668 |
|
|
2018
Q3 | $206K | Buy |
18,337
+2,294
| +14% | +$25.8K | ﹤0.01% | 3748 |
|
|
2018
Q2 | $205K | Sell |
16,043
-86,595
| -84% | -$1.11M | ﹤0.01% | 3688 |
|
|
2018
Q1 | $1.74M | Buy |
102,638
+86,111
| +521% | +$1.46M | ﹤0.01% | 2708 |
|
|
2017
Q4 | $132K | Buy |
16,527
+49
| +0.3% | +$391 | ﹤0.01% | 3805 |
|
|
2017
Q3 | $128K | Sell |
16,478
-544
| -3% | -$4.23K | ﹤0.01% | 3931 |
|
|
2017
Q2 | $125K | Buy |
17,022
+1,131
| +7% | +$8.31K | ﹤0.01% | 3902 |
|
|
2017
Q1 | $118K | Buy |
15,891
+217
| +1% | +$1.61K | ﹤0.01% | 3676 |
|
|
2016
Q4 | $109K | Sell |
15,674
-23,175
| -60% | -$161K | ﹤0.01% | 3694 |
|
|
2016
Q3 | $320K | Sell |
38,849
-20
| -0.1% | -$165 | ﹤0.01% | 3383 |
|
|
2016
Q2 | $315K | Buy |
38,869
+24,092
| +163% | +$195K | ﹤0.01% | 3428 |
|
|
2016
Q1 | $75K | Buy |
+14,777
| New | +$75K | ﹤0.01% | 3896 |
|